Profile | GDS4284 / 1564129_a_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 541.246 | 65 |
GSM687648 | Patient 402 control | 525.502 | 64 |
GSM687653 | Patient 403 control | 420.499 | 62 |
GSM687658 | Patient 404 control | 620.933 | 67 |
GSM687663 | Patient 411 control | 503.697 | 63 |
GSM687668 | Patient 422 control | 360.757 | 59 |
GSM687673 | Patient 424 control | 660.798 | 67 |
GSM687678 | Patient 425 control | 476.306 | 62 |
GSM687683 | Patient 427 control | 585.292 | 65 |
GSM687688 | Patient 428 control | 537.35 | 65 |
GSM687695 | Patient 441 control | 1033.35 | 76 |
GSM687699 | Patient 443 control | 767.102 | 70 |
GSM687704 | Patient 444 control | 781.17 | 70 |
GSM687707 | Patient 448 control | 713.151 | 69 |
GSM687712 | Patient 449 control | 732.996 | 69 |
GSM687719 | Patient 450 control | 848.065 | 71 |
GSM687724 | Patient 451 control | 753.195 | 70 |
GSM687728 | Patient 452 control | 607.187 | 67 |
GSM687646 | Patient 401 treated 24h | 338.886 | 57 |
GSM687649 | Patient 402 treated 24h | 311.42 | 57 |
GSM687665 | Patient 411 treated 24h | 708.662 | 68 |
GSM687651 | Patient 402 treated 4 weeks | 558.849 | 65 |
GSM687667 | Patient 411 treated 4 weeks | 555.47 | 65 |
GSM687670 | Patient 422 treated 24h | 583.657 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 499.976 | 63 |
GSM687654 | Patient 403 treated 24h | 354.703 | 59 |
GSM687675 | Patient 424 treated 24h | 668.133 | 67 |
GSM687685 | Patient 427 treated 24h | 400.672 | 60 |
GSM687656 | Patient 403 treated 4 weeks | 482.672 | 64 |
GSM687677 | Patient 424 treated 4 weeks | 521.926 | 64 |
GSM687687 | Patient 427 treated 4 weeks | 487.1 | 63 |
GSM687692 | Patient 428 treated 4h | 515.778 | 64 |
GSM687716 | Patient 449 treated 4h | 456.723 | 63 |
GSM687722 | Patient 450 treated 4h | 853.51 | 71 |
GSM687680 | Patient 425 treated 24h | 555.854 | 65 |
GSM687690 | Patient 428 treated 24h | 394.957 | 61 |
GSM687700 | Patient 443 treated 24h | 1126.22 | 75 |
GSM687705 | Patient 444 treated 24h | 589.489 | 67 |
GSM687714 | Patient 449 treated 24h | 505.578 | 64 |
GSM687721 | Patient 450 treated 24h | 779.026 | 70 |
GSM687682 | Patient 425 treated 4 weeks | 355.57 | 59 |
GSM687694 | Patient 428 treated 4 weeks | 411.13 | 61 |
GSM687702 | Patient 443 treated 4 weeks | 582.118 | 65 |
GSM687718 | Patient 449 treated 4 weeks | 534.373 | 65 |
GSM687723 | Patient 450 treated 4 weeks | 637.271 | 67 |
GSM687661 | Patient 404 treated 4h | 609.889 | 66 |
GSM687710 | Patient 448 treated 4h | 409.493 | 61 |
GSM687726 | Patient 451 treated 4h | 564.603 | 65 |
GSM687730 | Patient 452 treated 4h | 1846.85 | 84 |
GSM687660 | Patient 404 treated 24h | 1134.35 | 78 |
GSM687697 | Patient 441 treated 24h | 932.999 | 73 |
GSM687709 | Patient 448 treated 24h | 569.313 | 66 |
GSM687725 | Patient 451 treated 24h | 737.73 | 69 |
GSM687729 | Patient 452 treated 24h | 824.027 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 556.777 | 65 |
GSM687731 | Patient 452 treated 4 weeks | 425.378 | 60 |